---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-25-000007"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2025-01-23T23:59:59+00:00"
generated_at: "2026-05-27T13:19:53.359741+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Elevance Health Q4 2024 adjusted EPS $3.84, FY 2025 guidance $34.15-$34.85; dividend raised 5% to $1.71

## Summary
- Q4 operating revenue $45.0B (+6% YoY); FY revenue $175.2B (+3%).
- Q4 GAAP EPS $1.81; adjusted EPS $3.84. FY GAAP EPS $25.68; adjusted EPS $33.04.
- Health Benefits Q4 operating margin 0.6% (down from 2.1% YoY) on higher Medicaid cost trend.
- Carelon Q4 adjusted operating margin 5.3% (up from 4.8% YoY); FY adjusted margin 5.8%.
- FY 2025 adjusted EPS guidance $34.15-$34.85; dividend raised 5% to $1.71, payable 3/25/25.

## SEC filing metadata
- accession: 0001156039-25-000007
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2025-01-23T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000007/0001156039-25-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603925000007/elv-20250123.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-25-000007
- JSON: https://secwatch.observer/filing/0001156039-25-000007.json
- Plain text: https://secwatch.observer/filing/0001156039-25-000007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.